Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
METAOD006: A Phase IIb, randomized, double-blind, placebo-controlled study to assess the efficacy (reduction in body weight), safety and tolerability of 24 weeks treatment with different doses of AOD9604 tablets (0.25 mg, 0.5 mg, 1 mg, or placebo) in 502 obese adults
Metabolic Pharmaceuticals terminated the program in February 2007
However, GMP certification covers manufacturing process rather than product efficacy
If you are not sure whether you should be given this medicine, talk to your doctor
From metabolic depletion to energy that supports your program
US$ 23.58
US$ 28.10
US$ 29.42
US$ 21.47
US$ 29.16
